SCHEMBL1587097

SCHEMBL1587097

N#Cc1cccc(-n2ccnn2)c1-n1ccnn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 12/20 0.39
KEAP1 Q14145 1/20 0.38
CYP1A2 P05177 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
CYP3A4 P08684 1/20 0.35
GAA P10253 1/20 0.35
CYP2D6 P10635 1/20 0.35
HCRTR1 O43613 2/20 0.34
HCRTR2 O43614 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HIF1A Q16665 1/20 0.34
CHRNB2 P17787 1/20 0.34
CYP2B6 P20813 1/20 0.34
MAOA P21397 1/20 0.34
CHRNA4 P43681 1/20 0.34
HTR3A P46098 1/20 0.34
CSNK2A2 P19784 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1586174 0.86 TSHR (0.43) NOTUMKEAP1CYP1A2CYP2C19HCRTR1
SCHEMBL30633068 0.85 NOTUM (0.42) NOTUMKEAP1CYP1A2CYP2C9CYP2C19
SCHEMBL1587098 0.85 NOTUM (0.42) NOTUMKEAP1CYP1A2CYP2C9CYP2C19
SCHEMBL27181822 0.84 NOTUM (0.41) NOTUMKDM4EALDH1A1SMN1; SMN2
SCHEMBL18284702 0.83 CYP19A1 (0.39) NOTUMKEAP1CYP1A2CYP2C9CYP2C19
SCHEMBL1586287 0.83 KEAP1 (0.44) NOTUMKEAP1HCRTR1HCRTR2KDM4E
SCHEMBL18284703 0.83 NOTUM (0.38) NOTUMKEAP1CYP1A2CYP2C9CYP2C19
SCHEMBL20142746 0.83 NOTUM (0.41) NOTUMKEAP1CYP1A2CYP2C19HCRTR1
SCHEMBL4531873 0.79 HCRTR1 (0.38) NOTUMKEAP1CYP1A2CYP2C9CYP2C19
SCHEMBL4531870 0.79 CYP19A1 (0.38) NOTUMKEAP1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2491031-A1 FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS Janssen Pharmaceutica N.V. (BE) 2012-08-29 EP disclosed
WO-2011050202-A1 FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2011-04-28 WO disclosed